- Home
- IMNM vs INSW Comparison
IMNM vs INSW Comparison
Compare IMNM & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | INSW |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IMNM | INSW |
|---|---|---|
| Price | $20.36 | $65.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $32.80 | ★ $69.33 |
| AVG Volume (30 Days) | ★ 907.5K | 628.7K |
| Earning Date | 06-08-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 6.56% |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ 6.23 |
| Revenue | $6,941,000.00 | ★ $843,302,000.00 |
| Revenue This Year | $18.41 | $2.80 |
| Revenue Next Year | $863.23 | N/A |
| P/E Ratio | ★ N/A | $10.73 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | $27.20 |
| 52 Week High | $27.65 | $78.51 |
Technical Indicators
Market Signals| Indicator | IMNM | INSW |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 45.35 |
| Support Level | $18.98 | $58.00 |
| Resistance Level | $22.57 | $78.51 |
| Average True Range (ATR) | 1.12 | 2.88 |
| MACD | -0.11 | -1.24 |
| Stochastic Oscillator | 17.98 | 2.15 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.